NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 150 filers reported holding NEKTAR THERAPEUTICS in Q2 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $20,217 | -50.7% | 16,304 | -62.8% | 0.00% | – |
| Q1 2024 | $40,969 | +179.5% | 43,855 | +69.1% | 0.00% | – |
| Q4 2023 | $14,657 | -57.2% | 25,942 | -54.9% | 0.00% | – |
| Q3 2023 | $34,264 | -84.3% | 57,528 | -84.8% | 0.00% | -100.0% |
| Q2 2023 | $217,655 | +77.0% | 378,398 | +595.3% | 0.00% | 0.0% |
| Q4 2022 | $122,989 | -27.2% | 54,420 | +22.4% | 0.00% | 0.0% |
| Q2 2022 | $169,000 | -72.2% | 44,471 | +57.9% | 0.00% | -94.7% |
| Q4 2019 | $608,000 | +85.4% | 28,157 | +205.9% | 0.02% | -75.6% |
| Q2 2019 | $328,000 | +60.0% | 9,205 | +47.6% | 0.08% | -11.4% |
| Q4 2018 | $205,000 | -50.0% | 6,237 | -7.3% | 0.09% | +60.0% |
| Q3 2018 | $410,000 | – | 6,726 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |